Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 350.00 | |
5 mg | In stock | $ 828.00 | |
10 mg | In stock | $ 1,130.00 | |
25 mg | In stock | $ 1,590.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 |
Description | PPI-1019 is an APP (β-amyloid A4) inhibitor for the treatment of neurological disorders and the study of Alzheimer's disease (AD). |
Targets&IC50 | β-Amyloid (1–42):1.6 μM |
In vitro | The MTT data for the PPI-1019 using SHY5Y cells after a 24 h aggregation of 10 μM Aβ-(1–42) with IC50 was 10 μM. The N-methylated peptides PPI-1019 show a reduction in cell toxicity at concentrations similar to that used in the thioflavin T assays (IC50=1.6 μM).[1] |
Synonyms | PPI1019, Apan |
Molecular Weight | 650.85 |
Formula | C36H54N6O5 |
CAS No. | 290828-45-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PPI-1019 290828-45-4 Neuroscience Beta Amyloid PPI 1019 PPI1019 Apan inhibitor inhibit